Question Bank › Outsized outside commitment, delivery just start

Outsized outside commitment, delivery just starting

Calls Tested
500
Answered YES
12
Hit Rate
2.4%
rare by design

OPKO Health, Inc. (OPK) — this company's answers

NO on the Q1 2022 call 2022-05-09 D
The model's full reasoning — Q1 2022 call → NOWe need to answer YES or NO based on the transcript. The question asks: does management describe that one or more outside parties have recently committed real business to the company that is large relative to the company's current size, with that committed business already beginning to convert but still mostly ahead of the reported results? We need to check all three conditions. Condition 1: The commitment is real and already made by the other side. Look for actual commitments, not just interest. Condition 2: It is disproportionate to the company as it stands today. Management conveys that this committed business is large relative to current revenue/output. Condition 3: Conversion has started but numbers still lag. Delivery/ramp has begun but most contribution is ahead. Let's examine the transcript. The call discusses OPKO's Q1 2022 results. Key topics: ModeX acquisition, Sema4/GeneDx transaction, Pfizer milestones for Somatrogon (Neglina) launches, BioReference testing volumes, Scarlet Health partnerships (Teladoc, MVP Healthcare), etc. We need to see if any outside party has committed real business that is large relative to OPKO's size, with conversion started but still ahead. Consider the Pfizer partnership: Pfizer launched Neglina in Germany, Japan, Canada, Australia. That triggered $85 million in milestones. But that's a milestone payment, not necessarily a commitment of future business. The question is about committed business that will convert to revenue. The milestones are already earned, but the revenue from product sales is not yet forecasted. However, the question asks about "committed business" from outside parties. The Pfizer launches are not a commitment from a customer; it's a partner launching a product. The revenue from sales is not yet known. Management says they have not forecasted royalty or gross profit share amounts until they develop actual history. So that's not a commitment of large business. Consider the Sema4 transaction: They sold GeneDx. That's a divestiture, not a commitment of business. Consider BioReference: They have contracts with schools, cruise lines, sports, etc. But those are ongoing testing contracts. Are they large relative to the company? The company's revenue is over $1 billion. The COVID testing is declining. The question is about a recent commitment that is large relative to size.

← Back to the full OPK analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that one or more OUTSIDE PARTIES — customers, partners, program sponsors, institutions, or similar counterparties — have RECENTLY committed real business TO the company that is LARGE RELATIVE TO THE COMPANY'S CURRENT SIZE, with that committed business ALREADY BEGINNING to convert but still mostly ahead of the reported results? Answer YES when management's own words convey ALL THREE of the following as one coherent, present-tense story, in whatever form fits the industry: (1) THE COMMITMENT IS REAL AND ALREADY MADE BY THE OTHER SIDE. An outside party has actually committed — signed, awarded, ordered, contracted, reserved, designated, expanded an existing relationship into a much bigger phase, or otherwise obligated itself — rather than merely expressed interest, entered discussions, or appeared in a pipeline. The commitment may be one large counterparty or several counterparties stepping up together, and it may take any form that fits the business: a major contract or program win, a large order or first big purchase, a proven customer moving from an initial engagement to a far larger one, a partner or institution building its own plans around what the company supplies, or committed volumes scheduled ahead. (2) IT IS DISPROPORTIONATE TO THE COMPANY AS IT STANDS TODAY. Management itself conveys — directly or plainly in substance — that this committed business is large relative to the company's current level of revenue, output, or activity: for example by calling it the largest in the company's history, comparing it to the size of the existing business, describing how the company must expand, hire, build, or reorganize to deliver it, or otherwise treating it as capable of meaningfully changing the company's scale rather than as routine business in the ordinary rhythm. (3) CONVERSION HAS STARTED BUT THE NUMBERS STILL LAG. Delivery, ramp, or early revenue from this committed business has already begun or is beginning now — real initial shipments, first deliveries, onboarding, production, or activity underway — while management makes clear that most of its contribution lies ahead of the results being reported, so today's numbers describe the company before the commitment lands. Answer NO if the forward story rests on pipeline, bids outstanding, negotiations, letters of intent, market opportunity, or demand the company still must win. NO if the committed business is routine in size for this company — ordinary orders, renewals, or backlog at its usual scale. NO if the commitment remains contingent on approvals, financing, or counterparty decisions not yet made. NO if the committed business is already substantially delivered and reflected in the reported results. NO if management is chiefly explaining delays, cancellations, or problems with a previously described commitment. NO if the commitment appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
AES The AES Corporation Q1 2024 2024-05-03 C+
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
NBTX Nanobiotix S.A. Q2 2023 2023-09-27 D
GVP GSE Systems, Inc. Q1 2023 2023-05-15 D
SYM Symbotic Inc. Q3 2022 2022-08-01 B+
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
ADSE ADS-TEC Energy PLC Q4 2021 2022-04-28 D
FAT FAT Brands Inc. Q4 2021 2022-03-21 F
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
CPK Chesapeake Utilities Corporation Q3 2017 2017-11-10 A
GOGO Gogo Inc. Q1 2016 2016-05-06 C+

How the model reasoned

ADSE · Q4 2021 → YESThe question is about whether management describes outside parties committing large business that's starting to convert but mostly ahead. YES The transcript describes a signed contract for the initial 50 units with a strategic customer, plus the customer's plans for more than 10,000 units over the next few years, which management presents as a committed expansion. This is framed as disproportionate to the company's current scale, given 2021 revenue of €33 million and 2022 guidance of €80–100 million, with the backlog exceeding €60 million (nearly double prior revenue) and expected to drive significant growth outside Germany.
FAT · Q4 2021 → YESThe question is about whether management describes outside parties committing real business that's large relative to the company's current size, already beginning to convert but mostly ahead of report...NO The transcript describes a development pipeline of 850 locations that are committed and mostly paid for by franchise partners, representing potential 33% unit growth. However, the language focuses on the pipeline as a future opportunity rather than recent commitments already converting into revenue.
FLUX · Q2 2022 → YESThe question is about whether management describes outside parties committing real business that's large relative to the company's size, already beginning to convert but mostly ahead of reported resul...YES The transcript shows management describing a record $31.4 million backlog from recent customer purchase orders totaling $19.

More from the question bank

Substance without an audienceUncontested runwayCostly self-restriction to protect one part Quarter of firsts: the period's story is buiVerification moment aheadNew business is being written on visibly betAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.